학술논문
Effects of once-weekly semaglutide 2.4 mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): Exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials
Document Type
Article
Author
Source
In: eClinicalMedicine . (eClinicalMedicine, January 2023, 55)
Subject
Language
English
ISSN
25895370